Efficacy and Safety of Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligorecurrence

被引：0
|
作者：
Lv, X. [1 ]
Wang, Y. [1 ]
Ai, J. [1 ]
Wang, Q. [1 ]
Wang, J. [2 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Hebei, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3089
引用
收藏
页码：E493 / E493
页数：1
相关论文
共 50 条
  • [41] Comparative Analysis of Concurrent Chemoradiotherapy Versus Chemotherapy Alone as First-Line Palliative Treatments for Advanced Esophageal Squamous Cell Carcinoma
    Wonglhow, Jirapat
    Wetwittayakhlang, Panu
    Sunpaweravong, Patrapim
    Sathitruangsak, Chirawadee
    Dechaphunkul, Arunee
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [42] Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced Non-small Cell Lung Cancer (NSCLC)
    Alessi, J.
    Elkrief, A.
    Ricciuti, B.
    Cortellini, A.
    Wang, X.
    Vaz, V. R.
    Barrichello, A.
    Lamberti, G.
    Fulgenzi, C.
    Pecci, F.
    Pinato, D. J.
    Schoenfeld, A. J.
    Awad, M. M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S358 - S359
  • [43] Immunological and nutritional predictors for first-line chemoimmunotherapy in advanced non-small cell lung cancer
    Takeda, Takayuki
    Ogura, Yuri
    Kataoka, Nobutaka
    Kunimatsu, Yusuke
    Tachibana, Yusuke
    Sugimoto, Takumi
    Tani, Nozomi
    Sato, Izumi
    Hirose, Kazuki
    Kato, Daishiro
    ANNALS OF ONCOLOGY, 2021, 32 : S334 - S334
  • [44] Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer
    Liu, Ying
    Ren, Zhonghai
    Yuan, Long
    Xu, Shuning
    Yao, Zhihua
    Qiao, Lei
    Li, Ke
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (10): : 2345 - 2350
  • [45] Efficacy of radiotherapy in combination with first-line immunotherapy and chemotherapy for advanced lung squamous cell carcinoma: a propensity score analysis
    Qin, Jian
    Yi, Shouhui
    Zhou, Hanjing
    Zeng, Chuan
    Zou, Minghua
    Zeng, Xuan
    Yang, Zhenzhou
    Huang, Yusheng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Efficacy and safety of KN046 plus paclitaxel/cisplatin as first-line treatment for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC).
    Xu, Jianming
    Liu, Rongrui
    Zhang, Yanqiao
    Xu, Nong
    Fan, Qingxia
    Gao, Shegan
    Pan, Hongming
    Cai, Mingquan
    Yan, Dong
    Liang, Qianqian
    Wu, Qiong
    Guo, Baohong
    Qi, Yakun
    Xu, Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer
    Kish, Jonathan
    Liassou, Djibril
    Hartman, John
    Lubinga, Solomon J.
    Chopra, Dhruv
    Feinberg, Bruce
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (05): : E129 - E135
  • [48] Treatment-Related Adverse Events in Patients with Advanced NSCLC Treated with First-Line Atezolizumab Chemoimmunotherapy
    Swarup, S.
    Thein, K.
    Sultan, A.
    Jahan, N.
    Quirch, M.
    Meda, S.
    Htut, T.
    Adhikari, N.
    Hlaing, P.
    Dash, A.
    Tun, A.
    Rehman, S.
    Hardwicke, F.
    Tijani, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S390 - S390
  • [49] New First-Line Systemic Treatment Options for Metastatic Esophageal Squamous Cell Carcinoma
    Gibson, Michael K.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 579 - 582
  • [50] First-line induction or consolidation chemotherapy combined with concurrent chemoradiotherapy for esophageal squamous cell carcinoma
    Zhao, Yan
    Li, Huiqing
    Li, Hua
    Zhang, Ziling
    Wen, Junpeng
    Li, Juan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (06)
12345